Skip to main content

Agitation Associated with Dementia Due to Alzheimer’s Disease News

Could a 'Brain Coach' Help Folks at Higher Risk for Alzheimer's?

TUESDAY, Nov. 28, 2023 – Personal trainers can help people increase their strength and their fitness. Could a “brain coach” be just as useful in preventing Alzheimer’s’ disease? A new study suggests ...

Dementia Incidence Increased With Termination of Metformin

FRIDAY, Oct. 27, 2023 – Terminating metformin treatment is associated with an increased incidence of dementia, according to a study published online Oct. 25 in JAMA Network Open. Scott C. Zimmerman,...

Risk for Dementia Reduced in Association With Antihypertensive Use

WEDNESDAY, Sept. 13, 2023 – Antihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 in JAMA Network...

Antipsychotic Use Increased for Seniors With Alzheimer, Related Dementias

TUESDAY, Sept. 12, 2023 – Antipsychotics are more often used by older adults receiving home health care (HHC) services with Alzheimer disease and related dementias (ADRD) versus those without ADRD,...

Otsuka and Lundbeck Announce U.S. FDA Approval of Supplemental New Drug Application (sNDA) for Rexulti (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease

PRINCETON, NJ and DEERFIELD, IL – May 10, 2023 – Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Lundbeck LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the sup...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Alzheimer's Disease

Related drug support groups

Rexulti